Area of research
Pediatrics, Perinatology and Child Health · Genetics
Research interest
Research interests include Fetal and Pediatric Neurological Disorders, Glioma Diagnosis and Treatment, Spine and Intervertebral Disc Pathology, and Intracranial Aneurysms: Treatment and Complications.
Anatomy-corrected metabolic asymmetry predicts seizure freedom after surgery in focal cortical dysplasia
Exploring perivascular epithelioid cell tumors (PEComas) in the CNS: insights from two case reports and a comprehensive literature review
Heterozygous mutations in the C-terminal domain of COPA underlie a complex autoinflammatory syndrome
Antiviral treatment with fluoxetine for rituximab‐associated chronic echovirus 13 meningoencephalitis and myofasciitis
Label-Set Loss Functions for Partial Supervision: Application to Fetal Brain 3D MRI Parcellation
Features of intracranial hemorrhage in cerebral venous thrombosis
Early goal-directed haemodynamic optimization of cerebral oxygenation in comatose survivors after cardiac arrest: the Neuroprotect post-cardiac arrest trial
Reliability of MR Imaging–Based Posterior Fossa and Brain Stem Measurements in Open Spinal Dysraphism in the Era of Fetal Surgery
Primary myxoid mesenchymal tumour with intracranial location: report of a case with a <i><scp>EWSR</scp>1</i>–<i><scp>ATF</scp>1</i> fusion
How does the interaction of presumed timing, location and extent of the underlying brain lesion relate to upper limb function in children with unilateral cerebral palsy?
10-year follow-up after implantation of the Bryan Cervical Disc Prosthesis
Clinical spectrum, underlying etiologies and radiological characteristics of cortical superficial siderosis
Integrating diffusion kurtosis imaging, dynamic susceptibility-weighted contrast-enhanced MRI, and short echo time chemical shift imaging for grading gliomas
CT Density Measurement and H:H Ratio Are Useful in Diagnosing Acute Cerebral Venous Sinus Thrombosis
Defining pseudoprogression in glioblastoma multiforme
Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
Novel COL4A1 mutations cause cerebral small vessel disease by haploinsufficiency